Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of GBP 13.43 million. The enterprise value is 11.35 million.

Market Cap	13.43M
Enterprise Value	11.35M

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	112.17M
Shares Outstanding	n/a
Shares Change (YoY)	+53.18%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	89.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.60
PB Ratio	1.70
P/TBV Ratio	1.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.33
EV / Sales	41.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.08.

Current Ratio	1.16
Quick Ratio	1.16
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-59.81

Financial Efficiency

Return on equity (ROE) is -70.37% and return on invested capital (ROIC) is -42.88%.

Return on Equity (ROE)	-70.37%
Return on Assets (ROA)	-34.77%
Return on Invested Capital (ROIC)	-42.88%
Return on Capital Employed (ROCE)	-103.23%
Revenue Per Employee	27,635
Profits Per Employee	-852,169
Employee Count	10
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.87% in the last 52 weeks. The beta is 0.33, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-39.87%
50-Day Moving Average	5.25
200-Day Moving Average	24.80
Relative Strength Index (RSI)	27.27
Average Volume (20 Days)	6,458

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of GBP 276,353 and -8.52 million in losses. Loss per share was -0.07.

Revenue	276,353
Gross Profit	-6.41M
Operating Income	-8.80M
Pretax Income	-8.52M
Net Income	-8.52M
EBITDA	-8.85M
EBIT	-8.80M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 2.71 million in cash and 616,860 in debt, giving a net cash position of 2.09 million.

Cash & Cash Equivalents	2.71M
Total Debt	616,860
Net Cash	2.09M
Net Cash Per Share	n/a
Equity (Book Value)	7.91M
Book Value Per Share	0.07
Working Capital	416,380

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.94M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,185.55%
Pretax Margin	-3,083.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.18%
Shareholder Yield	n/a
Earnings Yield	-63.45%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -6.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.6
Piotroski F-Score	n/a